Patients with SSc were linked to an increased risk for hematological malignancies, specifically B-cell malignancies.

The fungal compound verticillin A, discovered more than 50 years ago, has long been regarded for its potential cancer-fighting capabilities. S cientists have now managed to artificially synthesize the ...

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today ...

Jazz Pharmaceuticals plc  today announced the appointment of Thomas Riga as Chief Business Officer, effective January 1, 2026.Mr. Riga joined Jazz in April 2025 through the acquisition of Chimerix Inc ...

Mycophenolate mofetil treatment in patients with limited cutaneous systemic sclerosis is linked to a reduced need for escalation of vasoactive or vasodilator therapies for vascular complications.

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced highlights from the Company's 2025 achievements and provided ...

Adaptive Biotechnologies (NASDAQ:ADPT) used a presentation at the J.P. Morgan healthcare conference to outline growth drivers ...

Multiple sclerosis (MS) is a disorder that prompts the body's immune system to attack myelin, the protective sheath covering nerve cells in the brain, optic nerve and spinal cord. This can in turn ...

The role that Epstein-Barr Virus (EBV) plays in the development of Multiple Sclerosis may be caused a higher level of cross-reactivity, where the body's immune system binds to the wrong target, than ...

A study from Sweden’s Uppsala University discovered a link between microplastics and multiple sclerosis (MS). The research, published in the journal Environmental International, discovered that ...

“Forever chemicals” are synthetic compounds found in products like non-stick pans, waterproof clothing, dental floss and more items Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has ...